Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Association of carriers of single nucleotide polymorphisms rs206787 and rs516535 in gene BRD2 and rs3743123 in gene GJD2 with juvenile myoclonic epilepsy of Caucasian patients in the Siberia

Full Text:

Abstract

This article outlines recent findings on genetics of juvenile myoclonic epilepsy (JME), where JME occurrence is associated with polymorphic allelic variants in BRD2 gene (locus EJM3) and GJD2 gene (locus EJM2).

Objective: To establish risk factors for development of JME in the context of genetic predisposition; specifically, polymorphic allelic variants rs206787 and rs516535 in the BRD2 gene and rs3743123 in the GJD2 gene.

Materials and Methods: Using RT-PCR, we identified carriers of single nucleotide polymorphisms (SNPs) rs206787 and rs516535 in gene BRD2 and rs3743123 in gene GJD2, from samples of 79 JME patients and 150 healthy volunteers of European descent residing in the Siberian Federal District.

Results: We found complete linkage disequilibrium between studied loci in patients with JME and healthy controls, however there was no association between SNPs rs206787 and rs516535 and JME development in our study population (р > 0,05). Haplotype TT/TT for SNPs rs206787 and rs516535 in the BRD2 gene associated with photoparoxysmal response (OR = 3,6; 95% CI 1,37 – 9,48; p = 0,02) in JME patients. Homozygosity of allele T (rs3743123) in the GJD2 gene was associated with risk of JME development in our study population (OR = 2,66; 95% CI 1,24 – 5,74; р = 0,04).

Conclusion: These results strongly suggest that genotyping JME patients of European descent living in Siberia to identify carriers of haplotype TT/TT in BRD2 SNPs (locus EJM3) and T allele (rs3743123) in the GJD2 gene will enable personalised approach to JME diagnosis and management, as well as identification of high-risk individuals in affected families.

About the Authors

O. S. Shilkina
V. F. Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of Russian Federation
Russian Federation


N. A. Shnayder
V. F. Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of Russian Federation, V.M. Bechterev National Medical Research Center of Psychiatry and Neurology of the Ministry of Health of Russian Federation
Russian Federation


S. N. Zobova
V. F. Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of Russian Federation, Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences , the Separate Division "Research Institute of Medical Problems of the North"
Russian Federation


D. V. Dmitrenko
V. F. Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of Russian Federation
Russian Federation


P. V. Moskaleva
V.M. Bechterev National Medical Research Center of Psychiatry and Neurology of the Ministry of Health of Russian Federation
Russian Federation


References

1. Karlov VA, Freidkova NV. Juvenile myoclonic epilepsy. In: Karlov VA, editor. Epilepsiya u detei i vzroslykh zhenshchin i muzhchin [Epilepsy in children and adults women and men]. Moscow: Meditsina; 2010. P. 244–8.

2. Petrukhin AS, Kalinina LV, Anpilogova IE. Clinical-epidemiological characteristics of epilepsy in children living in Tulskaya territory. Pediatriya. Zhurnal im. G.N. Speranskogo. 2004;83(6):101-3. (In Russ.)

3. Mukhin KYu. Juvenile myoclonic epilepsy (Jantz syndrome). In: Mukhin KYu, Petrukhin AS. Idiopaticheskie formy epilepsii: sistematika, diagnostika, terapiya [Idiopathic forms of epilepsy: systematics, diagnosis, therapy]. Moscow: Art-Biznes-Tsentr; 2000. P. 120–35.

4. Martínez-Juárez IE, Alonso ME, Medina MT, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain. 2006 May;129(Pt 5):1269-80. Epub 2006 Mar 6.

5. Shilkina OS, Petrov KV, Diuzhakova AV, et al. Frequency of juvenile myoclonic epilepsy phenotypes in Siberia. World J Neurosci. 2016;(6):32-6. doi:10.4236/wjns.2016.61004.

6. Shnaider NA, Shilkina OS, Petrov KV, et al. Clinical-genetics heterogeneity of juvenile myoclonic epilepsy. Epilepsiya i paroksizmal'nye sostoyaniya. 2016;(2):20-36. (In Russ.). doi: 10.17749/2077-8333.2016.8.2.020-036.

7. Belousova ED. Genetics of epilepsy: What for and how to examine children with epilepsy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, neuropsychiatry, psychosomatics. 2014;6(1S):4-8. (In Russ.). doi:10.14412/2074-2711-2014-1S-4-8.

8. Greenberg DA, Stewart WC. How should we be searching for genes for common epilepsy? A critique and a prescription. Epilepsia. 2012 Sep;53 Suppl 4:72-80. doi: 10.1111/j.1528-1167.2012.03616.x.

9. Delgado-Escueta AV, Koeleman BP, Bailey JN, et al. The quest for juvenile myoclonic epilepsy genes. Epilepsy Behav. 2013 Jul;28 Suppl 1:S52-7. doi: 10.1016/j.yebeh.2012.06.033.

10. Online Mendelian Inheritance in Man. http://www.omim.org/

11. Delgado-Escueta AV. Advances in genetics of juvenile myoclonic epilepsies. Epilepsy Curr. 2007 May-Jun;7(3):61-7. Doi: 10.1111/j.1535-7511.2007.00171.x.

12. Bosco D, Haefliger JA, Meda P. Connexins: key mediators of endocrine function. Physiol Rev. 2011 Oct;91(4):1393-445. doi: 10.1152/physrev.00027.2010.

13. Pal DK, Durner M, Klotz I, et al. Complex inheritance and parent-of-origin effect in juvenile myoclonic epilepsy. Brain Dev. 2006 Mar;28(2):92-8. Epub 2006 Jan 18.

14. Shang E, Wang X, Wen D, et al. Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse. Dev Dyn. 2009 Apr;238(4):908-17. doi: 10.1002/dvdy.21911.

15. Pal DK, Greenberg DA. Major susceptibility genes for common idiopathic epilepsies: ELP4 in Rolandic epilepsy and BRD2 in juvenile myoclonic epilepsy. In: Noebels JL, Avoli M, Rogawski MA, et al, editors. Source. Jasper's Basic Mechanisms of the Epilepsies. 4th edition. Bethesda: National Center for Biotechnology Information; 2012.

16. Pal DK, Evgrafov OV, Tabares P, et al. BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy. Am J Hum Genet. 2003 Aug;73(2):261-70. Epub 2003 Jun 25. doi: 10.1086/377006

17. de Kovel CG, Pinto D, de Haan GJ, et al. Association analysis of BRD2 (RING3) and epilepsy in a Dutch population. Epilepsia. 2007 Nov;48(11):2191-2. doi: 10.1111/j.1528-1167.2007.01306.x

18. Lorenz S, Taylor KP, Gehrmann A, et al. Association of BRD2 polymorphisms with photoparoxysmal response. Neurosci Lett. 2006 May 29;400(1-2):135-9. Epub 2006 Mar 3.

19. Cavalleri G. Haplotype mapping in epilepsy genetics and pharmacogenetics. University College London; 2013. http://discovery.ucl.ac.uk/id/eprint/1445351

20. Mas C, Taske N, Deutsch S, et al. Association of theconnexin 36 gene with juvenile myoclonic epilepsy. J Med Genet. 2004 Jul;41(7):e93.

21. Hempelmann A, Heils A, Sander T. Confirmatory evidence for an association of the connexin-36 gene with juvenile myoclonic epilepsy. Epilepsy Res. 2006 Oct;71(2-3):223-8. Epub 2006 Jul 28.


For citation:


Shilkina O.S., Shnayder N.A., Zobova S.N., Dmitrenko D.V., Moskaleva P.V. Association of carriers of single nucleotide polymorphisms rs206787 and rs516535 in gene BRD2 and rs3743123 in gene GJD2 with juvenile myoclonic epilepsy of Caucasian patients in the Siberia. Neurology, Neuropsychiatry, Psychosomatics. 0;. (In Russ.)

Views: 67


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)